Viewing data from:

SPRINTEC

ANDA

ETHINYL ESTRADIOL; NORGESTIMATE | A075804 | BARR LABORATORIES INC

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Sprintec (2023)

Total Spending

$439K

Total Claims

21,168

Beneficiaries

4,913

Avg Cost/Unit

$0.41

Spending Trend

$700K(2019)→$798K(2020)→$582K(2021)→$487K(2022)→$439K(2023)

YoY Change:-5.7%

5yr CAGR:-2.3%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.035MG;0.25MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Sep 25, 2002

No patent or exclusivity listings for this strength.